BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 35451900)

  • 1. VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy.
    Arrigo A; Aragona E; Bandello F
    Ann Med; 2022 Dec; 54(1):1089-1111. PubMed ID: 35451900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
    Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
    Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early pars plana vitrectomy for proliferative diabetic retinopathy: update and review of current literature.
    Berrocal MH; Acaba-Berrocal L
    Curr Opin Ophthalmol; 2021 May; 32(3):203-208. PubMed ID: 33770016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.
    Obeid A; Su D; Patel SN; Uhr JH; Borkar D; Gao X; Fineman MS; Regillo CD; Maguire JI; Garg SJ; Hsu J
    Ophthalmology; 2019 Mar; 126(3):407-413. PubMed ID: 30077614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy.
    Sun JK; Glassman AR; Beaulieu WT; Stockdale CR; Bressler NM; Flaxel C; Gross JG; Shami M; Jampol LM;
    Ophthalmology; 2019 Jan; 126(1):87-95. PubMed ID: 30096354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy.
    Bandello F; Corvi F; La Spina C; Benatti L; Querques L; Capuano V; Naysan J; Chen X; Sarraf D; Parodi MB; Souied E; Freund KB; Querques G
    Br J Ophthalmol; 2016 Dec; 100(12):1611-1616. PubMed ID: 26951773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cell biology of intraocular vascular diseases].
    Ishibashi T
    Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-VEGF Therapy for Persistent Neovascularization after Complete Panretinal Photocoagulation in Proliferative Diabetic Retinopathy.
    Mehanna CJ; Abdul Fattah M; Haddad S; Tamim H; Ghazi N; Salti H
    Ophthalmol Retina; 2019 Jun; 3(6):473-477. PubMed ID: 31174668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal anti-vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a systematic review and network meta-analysis.
    Fallico M; Maugeri A; Lotery A; Longo A; Bonfiglio V; Russo A; Avitabile T; Pulvirenti A; Furino C; Cennamo G; Barchitta M; Agodi A; Reibaldi M
    Acta Ophthalmol; 2021 Sep; 99(6):e795-e805. PubMed ID: 33326183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does laser still have a role in the management of retinal vascular and neovascular diseases?
    Shah AM; Bressler NM; Jampol LM
    Am J Ophthalmol; 2011 Sep; 152(3):332-339.e1. PubMed ID: 21742309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Vascular Endothelial Growth Factor and Panretinal Photocoagulation Use after Protocol S for Proliferative Diabetic Retinopathy.
    Azad AD; Chen EM; Hinkle J; Rayess N; Wu D; Eliott D; Mruthyunjaya P; Parikh R
    Ophthalmol Retina; 2021 Feb; 5(2):151-159. PubMed ID: 32693033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pan-retinal laser photocoagulation on intravitreal vascular endothelial growth factor concentration in proliferative diabetic retinopathy.
    Nišić F; Pidro A; Lepara O; Fajkić A; Mioković AP; Suljić E; Nišić A; Kovačević I
    Rom J Ophthalmol; 2022; 66(3):265-270. PubMed ID: 36349176
    [No Abstract]   [Full Text] [Related]  

  • 13. Current and Future Pharmacologic Therapies for Diabetic Retinopathy.
    Villegas VM; Schwartz SG
    Curr Pharm Des; 2018; 24(41):4903-4910. PubMed ID: 30706803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
    Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
    Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial.
    Mirshahi A; Roohipoor R; Lashay A; Mohammadi SF; Abdoallahi A; Faghihi H
    Eur J Ophthalmol; 2008; 18(2):263-9. PubMed ID: 18320520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature.
    Chatziralli I; Loewenstein A
    Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452097
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of Panretinal Photocoagulation Plus Intravitreal Anti-VEGF Treatment Against PRP Alone for Diabetic Retinopathy: A Systematic Review With Meta-Analysis.
    Zhang W; Geng J; Sang A
    Front Endocrinol (Lausanne); 2022; 13():807687. PubMed ID: 35422768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving strategies in the management of diabetic retinopathy.
    Abu El-Asrar AM
    Middle East Afr J Ophthalmol; 2013; 20(4):273-82. PubMed ID: 24339676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of the anti-vascular endothelial growth factor intravitreal injection and panretinal photocoagulation for patients with proliferative diabetic retinopathy in South Korea.
    Lee HJ; Cho S; Park J; Jin Y; Kim HM; Jee D
    BMC Health Serv Res; 2023 Dec; 23(1):1388. PubMed ID: 38082399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy.
    Nicholson L; Ramu J; Chan EW; Bainbridge JW; Hykin PG; Talks SJ; Sivaprasad S
    JAMA Ophthalmol; 2019 Jun; 137(6):626-631. PubMed ID: 30973596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.